Ivax cut by Smith Barney to hold

Ivax Corp. was downgraded by Smith Barney Citigroup analyst Andrew Swanson to a hold rating from a buy rating following an agreement to be acquired by Teva Pharmaceutical Industries Ltd. for $7.4 billion. Ivax shares on Monday gained $2.29, or 10.01%, to close at $25.17 on volume of 49,496,000 shares versus the three-month running average of 2,048,110 shares.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.